Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 599

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Life‐time risk of different cancers in hereditary non‐polyposis colorectal cancer (hnpcc) syndrome

Aarnio, Markku, Mecklin, Jukka‐Pekka, Aaltonen, Lauri A., Nyström‐Lahti, Minna, Järvinen, Heikki J.·1995·International Journal of Cancer

Abstract

Identification of hereditary non‐polyposis colorectal cancer (HNPCC) indicates theoretical life‐time risks of 50% for the descendants of an affected family member and of 100% for the true gene carriers. However, besides colorectal cancer (CRC), many other cancer types and sites are also involved, which gives reason to evaluate the magnitude of risk for various other cancer types. A detailed pedigree analysis of 40 families with HNPCC identified 414 patients affected with cancer. A Kaplan‐Meier life‐table analysis for the cumulative risk of various cancers was performed on the basis of the 293 putative gene carriers who had adequate clinical and histological documentation of their tumors. Cumulative risks were highest for colorectal (78%) and endometrial cancers (43%, women only), followed by gastric, biliary tract, urinary tract and ovarian cancers (19‐9%). For the other probably HNPCC‐related cancer types, such as small bowel carcinoma and brain tumors, the life‐time risk was only 1%. The risk of any metachronous cancer reached 90% after treatment of CRC and 75% after endometrial cancer; the second tumor was most often a new CRC or endometrial cancer. CRC remains the most important cancer type in the HNPCC syndrome but does not develop in all gene carriers. This makes the decision of possible prophylactic colectomy for test‐detected gene carriers difficult. Of the many other cancer types involved, at least endometrial cancer is common enough to necessitate a specific surveillance program. © 1995 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ijc.2910640613

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 599

Metadata

Authors
Aarnio, M., Mecklin, J., Aaltonen, L. A., Nyström‐Lahti, M., & Järvinen, H. J.
Venue
International Journal of Cancer
Publisher
Wiley
Published
1995-12-20
Volume
64
Issue
6
Pages
430-433
ISSN
  • 0020-7136 (ISSN-L)
  • 1097-0215
OpenAlex
W2030080487
Cited by
599
References
16
FWCI
8.15
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Life‐time risk of different cancers in hereditary non‐polyposis colorectal cancer (hnpcc) syndrome. https://app.cochat.ai/papers/10.1002/ijc.2910640613
The paper
Aarnio, M., Mecklin, J., Aaltonen, L. A., Nyström‐Lahti, M., & Järvinen, H. J. (1995). Life‐time risk of different cancers in hereditary non‐polyposis colorectal cancer (hnpcc) syndrome. International Journal of Cancer. https://doi.org/10.1002/ijc.2910640613

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.